Skip to main content

Ondansetron Injection Shortage

Last Updated: May 22, 2017
Status: Resolved

Products Affected - Description
    • Ondansetron injection, AuroMedics, 2 mg/mL, 20 mL vial, 1 count, NDC 55150-0126-20
    • Ondansetron injection, Heritage, 2 mg/mL, 2 mL vial, 10 count, NDC 23155-0196-42
    • Ondansetron injection, Heritage, 2 mg/mL, 20 mL vial, 1 count, NDC 23155-0168-31
    • Ondansetron injection, Teva, 2 mg/mL, 20 mL vial, 1 count, NDC 00703-7226-01
    • Ondansetron injection, Teva, 2 mg/mL, 20 mL vial, 10 count, NDC 00703-7226-03
Reason for the Shortage
    • AuroMedics did not provide a reason for the shortage.
    • Fresenius Kabi has ondansetron injection available.
    • Heritage has ondansetron injection available.
    • Mylan Institutional has ondansetron injection available.
    • Novartis has Zofran injection available.
    • Pfizer has ondansetron injection available.
    • Sagent has ondansetron injection available.
    • Teva discontinued ondansetron 2 mg/mL 20 mL vials. The 2 mL vials are available.
    • West-Ward has ondansetron injection available.
    • Wockhardt has ondansetron injection on an FDA import alert.
Available Products
    • Zofran injection, Novartis, 2 mg/mL, 20 mL vial, 1 count, NDC 00173-0442-00
    • Ondansetron injection, AuroMedics, 2 mg/mL, 2 mL vial, 25 count, NDC 55150-0125-02
    • Ondansetron injection, Fresenius Kabi, 2 mg/mL, 2 mL prefilled syringe, 24 count, NDC 76045-0103-20
    • Ondansetron injection, Fresenius Kabi, 2 mg/mL, 2 mL vial, 25 count, NDC 63323-0373-02
    • Ondansetron injection, Fresenius Kabi, 2 mg/mL, 20 mL vial, 1 count, NDC 63323-0374-20
    • Ondansetron injection, Heritage, 2 mg/mL, 2 mL vial, 10 count, NDC 23155-0547-41
    • Ondansetron injection, Heritage, 2 mg/mL, 2 mL vial, 25 count, NDC 23155-0547-42
    • Ondansetron injection, Heritage, 2 mg/mL, 20 mL vial, 1 count, NDC 23155-0549-31
    • Ondansetron injection, Mylan Institutional, 2 mg/mL, 2 mL vial, 25 count, NDC 67457-0441-20
    • Ondansetron injection, Mylan Institutional, 2 mg/mL, 20 mL vial, 1 count, NDC 67457-0440-20
    • Ondansetron injection, Pfizer, 2 mg/mL, 2 mL iSecure syringe, 10 count, NDC 00409-1120-12
    • Ondansetron injection, Pfizer, 2 mg/mL, 2 mL vial, 25 count, NDC 00409-4755-03
    • Ondansetron injection, Pfizer, 2 mg/mL, 20 mL vial, 1 count, NDC 00409-4759-01
    • Ondansetron injection, Sagent, 2 mg/mL, 2 mL vial, 25 count, NDC 25021-0777-02
    • Ondansetron injection, Teva, 2 mg/mL, 2 mL vial, 25 count, NDC 00703-7221-04
    • Ondansetron injection, West-Ward, 2 mg/mL, 2 mL vial, 25 count, NDC 00641-6078-25
    • Ondansetron injection, West-Ward, 2 mg/mL, 20 mL vial, 1 count, NDC 00143-9890-01
    • Ondansetron injection, West-Ward, 2 mg/mL, 20 mL vial, 1 count, NDC 00641-6079-01

Estimated Resupply Dates

    • AuroMedics has ondansetron 2 mg/mL 2 mL vials on intermittent back order and the company is releasing product as it becomes available.

Updated

Updated May 22, 2017 by Leslie Jensen, PharmD, Drug Information Specialist. Created January 23, 2009 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer